AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT)

AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) was reported 306 times

AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADMINISTRATION RELATED REACTION 13 0.0667
1 LARYNGEAL WEB 1 0.0667
2 OCULAR SURFACE SQUAMOUS NEOPLASIA 1 0.0400
3 PENILE DERMATITIS 1 0.0159
4 NAIL DEFORMATION 1 0.0149
5 BETA 2 MICROGLOBULIN URINE INCREASED 1 0.0070
6 PARONYCHIA 29 0.0066
7 SCABIES 1 0.0058
8 PENILE BLISTER 1 0.0047
9 KL-6 INCREASED 1 0.0044
10 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
11 URINARY OCCULT BLOOD POSITIVE 1 0.0043
12 TONGUE NEOPLASM 1 0.0042
13 NAIL PIGMENTATION 1 0.0041
14 NON-SMALL CELL LUNG CANCER RECURRENT 1 0.0035
15 THROMBOPHLEBITIS MIGRANS 1 0.0029
16 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
17 CARDIOVASCULAR SYMPTOM 1 0.0026
18 ANAL ULCER 2 0.0024
19 VULVOVAGINAL RASH 1 0.0023
20 PHYSICAL DECONDITIONING 5 0.0019
21 HYPERAMYLASAEMIA 1 0.0018
22 EMBOLISM VENOUS 5 0.0016
23 CARCINOEMBRYONIC ANTIGEN INCREASED 3 0.0015
24 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
25 NASAL CRUSTING 1 0.0015
26 HEAT ILLNESS 1 0.0015
27 EFFUSION 2 0.0015
28 CUTANEOUS SYMPTOM 1 0.0015
29 ANGULAR CHEILITIS 1 0.0014
30 LIP EROSION 1 0.0014
31 CREATINE KINASE INCREASED 1 0.0013
32 GENITAL ULCERATION 1 0.0013
33 METAPNEUMOVIRUS INFECTION 1 0.0013
34 GROWTH OF EYELASHES 1 0.0013
35 ABDOMINAL SYMPTOM 1 0.0012
36 AMYLASE INCREASED 4 0.0011
37 HYPOPROTEINAEMIA 2 0.0011
38 HYPOALBUMINAEMIA 8 0.0010
39 BLOOD ALBUMIN DECREASED 8 0.0010
40 DERMATITIS ACNEIFORM 6 0.0010
41 RADIATION PNEUMONITIS 2 0.0009
42 PNEUMONIA STREPTOCOCCAL 1 0.0009
43 TINEA INFECTION 1 0.0009
44 CYTOPENIA 11 0.0009
45 MUCOSAL HAEMORRHAGE 1 0.0009
46 ORAL MUCOSA EROSION 1 0.0008
47 CALCIUM DEFICIENCY 1 0.0008
48 RHINALGIA 2 0.0007
49 INVESTIGATION ABNORMAL 1 0.0007
50 NOROVIRUS INFECTION 1 0.0007
51 COCCYDYNIA 1 0.0007
52 MENTAL FATIGUE 1 0.0007
53 SKIN EROSION 2 0.0006
54 SKULL FRACTURE 1 0.0006
55 LISTLESS 2 0.0006
56 INJECTION RELATED REACTION 1 0.0006
57 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
58 GASTROINTESTINAL OEDEMA 1 0.0006
59 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
60 INDURATION 1 0.0006
61 TETANY 1 0.0005
62 INJECTION SITE CELLULITIS 1 0.0005
63 GINGIVAL RECESSION 1 0.0005
64 PURULENCE 1 0.0005
65 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
66 EAR HAEMORRHAGE 1 0.0005
67 ATRIAL THROMBOSIS 1 0.0005
68 INFUSION RELATED REACTION 32 0.0005
69 CORNEAL DISORDER 1 0.0005
70 DANDRUFF 1 0.0005
71 SCAB 5 0.0004
72 HAIR GROWTH ABNORMAL 3 0.0004
73 PATELLA FRACTURE 1 0.0004
74 DISCOURAGEMENT 1 0.0004
75 PULMONARY TOXICITY 3 0.0004
76 HAEMATOTOXICITY 4 0.0004
77 TUMOUR MARKER INCREASED 2 0.0004
78 ORGANISING PNEUMONIA 2 0.0004
79 URINE OUTPUT INCREASED 1 0.0004
80 ANAL FISSURE 2 0.0004
81 RENAL TUBULAR DISORDER 1 0.0004
82 SKIN TOXICITY 2 0.0004
83 SKIN ATROPHY 2 0.0003
84 LUNG ADENOCARCINOMA 1 0.0003
85 SKIN DISORDER 11 0.0003
86 DYSCHEZIA 1 0.0003
87 PIGMENTATION DISORDER 2 0.0003
88 PNEUMONIA VIRAL 1 0.0003
89 CUSHINGOID 1 0.0003
90 WOUND COMPLICATION 1 0.0003
91 DEPRESSIVE SYMPTOM 1 0.0003
92 GLOSSITIS 1 0.0003
93 FIBRIN D DIMER INCREASED 1 0.0003
94 SKIN WEEPING 1 0.0003
95 STOMATITIS 17 0.0003
96 NEUTROPHIL COUNT DECREASED 11 0.0003
97 LEUKOENCEPHALOPATHY 1 0.0003
98 PROTEIN TOTAL DECREASED 1 0.0003
99 CATHETER SITE INFECTION 1 0.0003
100 GINGIVAL PAIN 2 0.0003
101 MYELOSUPPRESSION 9 0.0002
102 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
103 GASTROINTESTINAL PERFORATION 1 0.0002
104 ONYCHOMADESIS 1 0.0002
105 HYPERPYREXIA 1 0.0002
106 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
107 CHAPPED LIPS 1 0.0002
108 SKIN TIGHTNESS 1 0.0002
109 CARDIAC TAMPONADE 1 0.0002
110 NON-SMALL CELL LUNG CANCER 1 0.0002
111 RASH VESICULAR 1 0.0002
112 DIZZINESS POSTURAL 2 0.0002
113 INJECTION SITE INFLAMMATION 1 0.0002
114 MOTOR DYSFUNCTION 2 0.0002
115 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
116 PRODUCT SIZE ISSUE 1 0.0002
117 GINGIVITIS 1 0.0002
118 CHEILITIS 1 0.0002
119 INTESTINAL ISCHAEMIA 1 0.0002
120 INTRACRANIAL PRESSURE INCREASED 1 0.0002
121 HERPES VIRUS INFECTION 1 0.0002
122 ENTEROCOLITIS 1 0.0002
123 INJECTION SITE VESICLES 1 0.0002
124 MENINGITIS 1 0.0001
125 HAIR TEXTURE ABNORMAL 2 0.0001
126 METASTASES TO LYMPH NODES 1 0.0001
127 ENCEPHALITIS 1 0.0001
128 LARGE INTESTINE PERFORATION 1 0.0001
129 HYPERTRANSAMINASAEMIA 1 0.0001
130 DERMATITIS 3 0.0001
131 THERMAL BURN 1 0.0001
132 ORAL DISORDER 1 0.0001
133 MOUTH HAEMORRHAGE 1 0.0001
134 BLOOD PRESSURE DECREASED 9 0.0001
135 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
136 ECZEMA 7 0.0001
137 HYPOAESTHESIA ORAL 2 0.0001
138 TROPONIN INCREASED 1 0.0001
139 OEDEMA 7 0.0001
140 SHOCK HAEMORRHAGIC 1 0.0001
141 CEREBRAL INFARCTION 3 0.0001
142 HICCUPS 1 0.0001
143 PYELONEPHRITIS 1 0.0001
144 MUCOSAL INFLAMMATION 3 0.0001
145 NAIL DISORDER 1 0.0001
146 ANAL INCONTINENCE 1 0.0001
147 RASH 47 0.0001
148 OXYGEN SATURATION DECREASED 6 0.0001
149 FEBRILE NEUTROPENIA 7 0.0001
150 LIVER FUNCTION TEST ABNORMAL 3 0.0001
151 HAEMORRHOIDS 2 0.0001
152 ORAL HERPES 2 0.0001
153 INJECTION SITE RASH 3 0.0001
154 EYE DISCHARGE 1 0.0001
155 TRANSFUSION 1 0.0001
156 HAEMATOCHEZIA 5 0.0001
157 MALNUTRITION 1 0.0001
158 SKIN INFECTION 1 0.0001
159 THROMBOSIS 7 0.0001
160 GASTRIC HAEMORRHAGE 1 0.0001
161 EYELID OEDEMA 1 0.0001
162 INTERSTITIAL LUNG DISEASE 4 0.0001
163 C-REACTIVE PROTEIN INCREASED 3 0.0001
164 NOCTURIA 1 0.0001
165 GENERALISED OEDEMA 1 0.0001
166 TOOTH EXTRACTION 1 0.0001
167 CELLULITIS 4 0.0001
168 INJECTION SITE IRRITATION 1 0.0001
169 HYPOPHAGIA 2 0.0001
170 BEDRIDDEN 1 0.0001
171 PULMONARY CONGESTION 1 0.0001
172 SARS-COV-2 TEST POSITIVE 1 0.0001
173 EYE HAEMORRHAGE 1 0.0001
174 DRY SKIN 10 0.0001
175 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
176 IMPAIRED GASTRIC EMPTYING 1 0.0001
177 HEPATIC ENZYME INCREASED 5 0.0001
178 RENAL IMPAIRMENT 6 0.0001
179 HYPOKINESIA 1 0.0001
180 LIVER DISORDER 3 0.0001
181 SKIN HAEMORRHAGE 1 0.0001
182 EPISTAXIS 5 0.0001
183 BLOOD POTASSIUM DECREASED 2 0.0001
184 OEDEMA PERIPHERAL 8 0.0001
185 INJECTION SITE ERYTHEMA 8 0.0001
186 DELUSION 1 0.0001
187 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
188 SENSORY DISTURBANCE 1 0.0001
189 DEEP VEIN THROMBOSIS 4 0.0001
190 METASTASES TO BONE 1 0.0001
191 COAGULOPATHY 1 0.0001
192 URINARY RETENTION 2 0.0001
193 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
194 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
195 ORTHOSTATIC HYPOTENSION 1 0.0001
196 HYPOXIA 2 0.0001
197 COLD SWEAT 1 0.0001
198 HEAD DISCOMFORT 1 0.0001
199 PLATELET COUNT DECREASED 6 0.0001
200 DECREASED APPETITE 13 0.0001
201 TREATMENT NONCOMPLIANCE 3 0.0001
202 HEPATIC FUNCTION ABNORMAL 2 0.0001
203 HYPONATRAEMIA 3 0.0001
204 ACNE 4 0.0001
205 GASTRIC ULCER 1 0.0001
206 PULMONARY EMBOLISM 5 0.0001
207 PROTEINURIA 1 0.0001
208 EAR PAIN 1 0.0001
209 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
210 IRRITABILITY 3 0.0000
211 CYTOKINE RELEASE SYNDROME 1 0.0000
212 PRODUCT ADMINISTRATION ERROR 1 0.0000
213 FLUSHING 5 0.0000
214 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
215 MYALGIA 8 0.0000
216 LIVER FUNCTION TEST INCREASED 1 0.0000
217 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
218 SEPTIC SHOCK 2 0.0000
219 MELAENA 1 0.0000
220 PANCREATITIS ACUTE 1 0.0000
221 INJECTION SITE REACTION 3 0.0000
222 ADVERSE EVENT 4 0.0000
223 MUSCLE TWITCHING 1 0.0000
224 PERICARDIAL EFFUSION 1 0.0000
225 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
226 ARRHYTHMIA 2 0.0000
227 OCULAR HYPERAEMIA 2 0.0000
228 NEUROPATHY PERIPHERAL 4 0.0000
229 COMA 2 0.0000
230 NEURALGIA 1 0.0000
231 PYREXIA 14 0.0000
232 HEART RATE INCREASED 4 0.0000
233 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
234 PNEUMONIA ASPIRATION 1 0.0000
235 HAEMATEMESIS 1 0.0000
236 ERYTHEMA 8 0.0000
237 ANAPHYLACTIC SHOCK 1 0.0000
238 UNRESPONSIVE TO STIMULI 1 0.0000
239 HAEMORRHAGE 4 0.0000
240 DEAFNESS 1 0.0000
241 MUSCULOSKELETAL PAIN 2 0.0000
242 PAIN OF SKIN 1 0.0000
243 BLOOD BILIRUBIN INCREASED 1 0.0000
244 PNEUMONITIS 1 0.0000
245 CONSTIPATION 8 0.0000
246 MENTAL STATUS CHANGES 1 0.0000
247 WOUND 1 0.0000
248 BLISTER 2 0.0000
249 MUSCULAR WEAKNESS 4 0.0000
250 RED BLOOD CELL COUNT DECREASED 1 0.0000
251 ANGINA PECTORIS 1 0.0000
252 HYPOTENSION 7 0.0000
253 HYPERSOMNIA 1 0.0000
254 DYSSTASIA 1 0.0000
255 CHILLS 4 0.0000
256 ASCITES 1 0.0000
257 TACHYCARDIA 3 0.0000
258 URINARY INCONTINENCE 1 0.0000
259 WHEEZING 2 0.0000
260 CORONARY ARTERY DISEASE 1 0.0000
261 MUSCLE SPASMS 6 0.0000
262 LIMB DISCOMFORT 1 0.0000
263 DRUG-INDUCED LIVER INJURY 1 0.0000
264 PRURITUS 12 0.0000
265 IMPAIRED HEALING 1 0.0000
266 EYE DISORDER 1 0.0000
267 STAPHYLOCOCCAL INFECTION 1 0.0000
268 VISUAL ACUITY REDUCED 1 0.0000
269 NIGHTMARE 1 0.0000
270 CEREBRAL HAEMORRHAGE 1 0.0000
271 HYPERGLYCAEMIA 1 0.0000
272 DYSURIA 1 0.0000
273 PAIN IN EXTREMITY 8 0.0000
274 CHEST PAIN 5 0.0000
275 EYE SWELLING 1 0.0000
276 HYPOAESTHESIA 4 0.0000
277 DYSARTHRIA 1 0.0000
278 HOT FLUSH 2 0.0000
279 OFF LABEL USE 22 0.0000
280 MALAISE 11 0.0000
281 LUNG NEOPLASM MALIGNANT 1 0.0000
282 SKIN EXFOLIATION 2 0.0000
283 NEUTROPENIA 3 0.0000
284 SKIN DISCOLOURATION 1 0.0000
285 HYPOKALAEMIA 1 0.0000
286 OROPHARYNGEAL PAIN 2 0.0000
287 WEIGHT DECREASED 6 0.0000
288 NAUSEA 17 0.0000
289 COGNITIVE DISORDER 1 0.0000
290 RASH ERYTHEMATOUS 1 0.0000
291 LUNG DISORDER 1 0.0000
292 ALOPECIA 4 0.0000
293 SOMNOLENCE 4 0.0000
294 CHEST DISCOMFORT 2 0.0000
295 HOSPITALISATION 3 0.0000
296 INFLAMMATION 1 0.0000
297 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
298 PANCYTOPENIA 1 0.0000
299 ABDOMINAL DISCOMFORT 3 0.0000
300 BACK PAIN 4 0.0000
301 SURGERY 1 0.0000
302 NASAL CONGESTION 1 0.0000
303 PLEURAL EFFUSION 1 0.0000
304 LOSS OF CONSCIOUSNESS 2 0.0000
305 DEHYDRATION 2 0.0000
306 INJECTION SITE PRURITUS 1 0.0000
307 VISION BLURRED 2 0.0000
308 COUGH 4 0.0000
309 FATIGUE 11 0.0000
310 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
311 DIZZINESS 7 0.0000
312 DIARRHOEA 9 0.0000
313 UNDERDOSE 1 0.0000
314 HALLUCINATION 1 0.0000
315 PERIPHERAL SWELLING 2 0.0000
316 VOMITING 6 0.0000
317 HEADACHE 8 0.0000
318 INJECTION SITE BRUISING 1 0.0000
319 CARDIAC FAILURE 1 0.0000
320 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
321 DYSPNOEA 7 0.0000
322 TREMOR 2 0.0000
323 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
324 CEREBROVASCULAR ACCIDENT 2 0.0000
325 MYOCARDIAL INFARCTION 2 0.0000
326 MUSCULOSKELETAL STIFFNESS 1 0.0000
327 ADVERSE DRUG REACTION 1 0.0000
328 NASOPHARYNGITIS 2 0.0000
329 DYSPHAGIA 1 0.0000
330 ATRIAL FIBRILLATION 1 0.0000
331 PRODUCT DOSE OMISSION ISSUE 3 0.0000
332 SYNCOPE 1 0.0000
333 PAIN 6 0.0000
334 ABDOMINAL PAIN UPPER 2 0.0000
335 HYPERTENSION 2 0.0000
336 FALL 3 0.0000
337 SEPSIS 1 0.0000
338 THROMBOCYTOPENIA 1 0.0000
339 WEIGHT INCREASED 2 0.0000
340 SEIZURE 1 0.0000
341 ABDOMINAL PAIN 2 0.0000
342 PALPITATIONS 1 0.0000
343 FEELING ABNORMAL 2 0.0000
344 ASTHENIA 3 0.0000
345 RENAL FAILURE 1 0.0000
346 INFECTION 1 0.0000
347 BLOOD PRESSURE INCREASED 1 0.0000
348 ACUTE KIDNEY INJURY 1 0.0000
349 INJECTION SITE PAIN 2 0.0000
350 PARAESTHESIA 1 0.0000
351 CONFUSIONAL STATE 1 0.0000
352 URTICARIA 1 0.0000
353 ANAEMIA 1 0.0000
354 GAIT DISTURBANCE 1 0.0000
355 DEPRESSION 1 0.0000
356 ANXIETY 1 0.0000
357 ARTHRALGIA 1 0.0000
358 DEATH 1 0.0000